A prospective study of CD8+ T-cell mediated immunity to cytomegalovirus (CMV) as a predictor of CMV disease

被引：0
|
作者：
Kumar, Deepali [1 ]
Chernenko, Susan [3 ]
Moussa, George [3 ]
Preiksaitis, Jutta [2 ]
Doucette, Karen [1 ]
Manuel, Oriol [2 ]
Cobos, Isabel [1 ]
Humar, Atul [1 ]
机构：
[1] Univ Alberta, Edmonton, AB, Canada
[2] Univ Alberta, Provincial Publ Hlth Lab, Edmonton, AB, Canada
[3] Univ Toronto, Toronto, ON, Canada
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2008年 / 8卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：266 / 266
页数：1
相关论文
共 50 条
  • [1] CD8+ T-cell immunity to cytomegalovirus
    Moss, P
    Khan, N
    HUMAN IMMUNOLOGY, 2004, 65 (05) : 456 - 464
  • [2] Linking CMV serostatus to episodes of CMV reactivation following lung transplantation by measuring CMV-specific CD8+ T-cell immunity
    Westall, G. P.
    Mifsud, N. A.
    Kotsimbos, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (08) : 1749 - 1754
  • [3] Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: correlation with protection from CMV disease
    Stone, SF
    Price, P
    French, MA
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (04) : 585 - 588
  • [4] CMV-Specific CD8+ T-CELL Function Is NOT Impaired In CLL
    te Raa, Doreen
    Pascutti, Fernanda
    Garcia-Vallejo, Juan J.
    Reinen, Emilie
    Remmerswaal, Ester B. M.
    Van Lier, Rene A. W.
    Eldering, Eric
    Van Oers, Marinus H. J.
    Tonino, Sanne H.
    Kater, Arnon P.
    BLOOD, 2013, 122 (21)
  • [5] Cytomegalovirus (CMV) Reactivation and CMV-Specific Cell-Mediated Immunity After Chimeric Antigen Receptor T-Cell Therapy
    Kampouri, Eleftheria
    Ibrahimi, Sarah S.
    Xie, Hu
    Wong, Elizabeth R.
    Hecht, Jessica B.
    Sekhon, Mandeep K.
    Vo, Alythia
    Stevens-Ayers, Terry L.
    Green, Damian J.
    Gauthier, Jordan
    Maloney, David G.
    Perez, Ailyn
    Jerome, Keith R.
    Leisenring, Wendy M.
    Boeckh, Michael J.
    Hill, Joshua A.
    CLINICAL INFECTIOUS DISEASES, 2024, 78 (04) : 1022 - 1032
  • [6] Human cytomegalovirus (CMV)-specific CD8+ T cell responses are reduced in HIV-infected individuals with a history of CMV disease despite CD4+ T cell recovery
    Singh, K. P.
    Howard, J. L.
    Wild, S. P.
    Jones, S. L.
    Hoy, J.
    Lewin, S. R.
    CLINICAL IMMUNOLOGY, 2007, 124 (02) : 200 - 206
  • [7] Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON®-CMV
    Walker, S.
    Fazou, C.
    Crough, T.
    Holdsworth, R.
    Kiely, P.
    Veale, M.
    Bell, S.
    Gailbraith, A.
    McNeil, K.
    Jones, S.
    Khanna, R.
    TRANSPLANT INFECTIOUS DISEASE, 2007, 9 (02) : 165 - 170
  • [8] Using a commercially available assay that measures cytomegalovirus (CMV)-specific T-cell immunity to predict protection against CMV: A prospective, blinded clinical study
    Almaghlouth, Nouf K.
    Arvanitis, Panagiotis
    Vieira, Kendra
    London, Abby
    Farmakiotis, Dimitrios
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2024, 108 (02)
  • [9] Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events
    Ralph Rogers
    Kapil Saharia
    Aditya Chandorkar
    Zoe F. Weiss
    Kendra Vieira
    Sophia Koo
    Dimitrios Farmakiotis
    BMC Infectious Diseases, 20
  • [10] Assessing the differential impact of chronic CMV and treated HIV infection on CD8+ T-cell differentiation in a matched cohort study: is CMV the key?
    Matthias C. Mueller
    Winfried V. Kern
    Susanne Usadel
    Marie-Christin Pauly
    Toni Cathomen
    Ulrich Salzer
    AIDS Research and Therapy, 18
12345